MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cgh.2026.01.028

Медицинская библиотека · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026

Beyond Eosinophils: Redefining the Spectrum of Esophageal Inflammatory Diseases Through an Immune-Centric Paradigm.

Bertin Luisa, Pasta Andrea, Wechsler Joshua B, Ghisa Matteo, Calabrese Francesco, Navazzotti Giulia, Grillo Federica, Mastracci Luca, Visaggi Pierfrancesco, de Bortoli Nicola, Fassan Matteo, Marabotto Elisa, Savarino Edoardo Vincenzo

СтатьяОбзорПеревод в очереди

Аннотация

BACKGROUND & AIMS: Traditional classification of esophageal inflammatory diseases (EIDs) relies on predominant cell infiltrates, with eosinophilic esophagitis (EoE) defined by ≥15 eosinophils per high-power field (hpf). However, although cell count thresholds remain clinically useful for defining certain variants, this paradigm alone does not fully capture the spectrum of immune-mediated esophageal inflammation or the complexity of therapeutic responses.

METHODS

We conducted a comprehensive narrative review of EID literature, emphasizing recent advances in molecular characterization, clinical phenotyping, and therapeutic approaches for classical EoE and its variants.

RESULTS

Four distinct variants exist beyond classical EoE: EoE-like esophagitis (histologic EoE features with <15 eosinophils/hpf), lymphocytic esophagitis (≥30 lymphocytes/hpf), nonspecific esophagitis (mixed inflammatory infiltrates), and mast cell esophagitis (elevated intraepithelial mast cells). Each variant demonstrates unique demographic patterns, molecular signatures, and inflammatory pathways. EoE-like esophagitis shows interleukin-13 pathway overlap with classical EoE and may progress to EoE (62.2% by 6 years), whereas other variants represent distinct T helper type 1-driven or mixed inflammatory entities. Failed clinical trials targeting eosinophil depletion underscore the inadequacy of cell-centric therapeutic approaches, whereas multi-pathway inhibitors like dupilumab demonstrate superior efficacy.

CONCLUSIONS

An immune-centric approach recognizing distinct inflammatory pathways across EIDs offers opportunities for precision medicine, earlier intervention, and development of variant-specific biomarkers and targeted therapies. This paradigm shift is essential for advancing the field beyond arbitrary cell count thresholds toward mechanistic understanding of esophageal inflammation.

Для цитирования: Bertin Luisa, Pasta Andrea, Wechsler Joshua B, Ghisa Matteo, Calabrese Francesco, Navazzotti Giulia, Grillo Federica, Mastracci Luca, Visaggi Pierfrancesco, de Bortoli Nicola, Fassan Matteo, Marabotto Elisa, Savarino Edoardo Vincenzo. Beyond Eosinophils: Redefining the Spectrum of Esophageal Inflammatory Diseases Through an Immune-Centric Paradigm.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2026. DOI: 10.1016/j.cgh.2026.01.028.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.